Original Publication Date: 1 March, 2016
Publication / Source: Future Oncology
Authors: Martin R Chasen & Bernardo L Rapoport
Chemotherapy-induced nausea and vomiting (CINV), both acute and delayed, has a dramatic effect on the well-being and quality of life of patients with cancer. Improved understanding of the mechanisms involved in CINV has led to the development of agents targeting the 5-HT3 receptor as well as the NK-1 receptor.